SCHEMBL827328

SCHEMBL827328

C=CCOc1ccc(C(c2ccc(OCC=C)cc2)(C(F)(F)F)C(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.46
CA1 P00915 3/20 0.46
CA9 Q16790 3/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
AGER Q15109 1/20 0.40
MAPT P10636 5/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
POLB P06746 2/20 0.40
TP53 P04637 1/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP2D6 P10635 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15096039 0.92 ALDH1A1 (0.42) CA12CA1CA9CA2CA7
SCHEMBL17860084 0.92 ESR1 (0.56) CA12CA1CA9CA2CA7
SCHEMBL11987211 0.88 CA12 (0.38) CA12CA1CA9CA2CA7
SCHEMBL1400474 0.85 CA12 (0.49) CA12CA1CA9CA2CA7
Formic Acid SCHEMBL15743043 0.81 ALDH1A1 (0.46) CA12CA1CA9CA2CA7
1,4-Diallyloxybenzene SCHEMBL302448 0.79 CA12 (0.63) CA12CA1CA9CA2CA7
SCHEMBL24406294 0.77 KDM4E (0.41) ESR1ESR2MAPTMEN1LMNA
SCHEMBL11322795 0.77 CA12 (0.49) CA12CA1CA9CA2CA7
SCHEMBL15880460 0.77 CA12 (0.49) CA12CA1CA9CA2CA7
SCHEMBL827011 0.77 CA12 (0.49) CA12CA1CA9CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116023753-B Modified resin composition, prepreg, laminated board and printed wiring board 广东盈骅新材料科技有限公司 2025-03-04 CN claimed
CN-119391133-A Modified allyl benzoxazine resin composition, build-up film, preparation method and application thereof 清华珠三角研究院 2025-02-07 CN claimed
CN-116023753-A Modified resin composition, prepreg, laminated board and printed wiring board 广东盈骅新材料科技有限公司 2023-04-28 CN claimed
US-8143362-B2 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-03-27 US claimed
US-20100331444-A1 COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF 3M ESPE AG (A WHOLLY-OWNED SUBSIDUARY OF 3M COMPANY) 2010-12-30 US claimed
US-7807730-B2 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M ESPE AG (DE) 2010-10-05 US claimed
WO-2026098249-A1 MODIFIED ALLYL BENZOXAZINE RESIN COMPOSITION, BUILD-UP FILM, PREPARATION METHOD THEREFOR, AND USE THEREOF 清华珠三角研究院 2026-05-15 WO disclosed
CN-116023753-B Modified resin composition, prepreg, laminated board and printed wiring board 广东盈骅新材料科技有限公司 2025-03-04 CN disclosed
CN-119391133-A Modified allyl benzoxazine resin composition, build-up film, preparation method and application thereof 清华珠三角研究院 2025-02-07 CN disclosed
CN-119391133-A Modified allyl benzoxazine resin composition, build-up film, preparation method and application thereof 清华珠三角研究院 2025-02-07 CN disclosed
CN-116253625-B Fluorine-containing allyl compound, modified bismaleimide resin, preparation method and application thereof 广东盈骅新材料科技有限公司 2024-11-26 CN disclosed
US-11773207-B2 Thiol compound, method for synthesizing same, and uses for said thiol compound SHIKOKU CHEMICALS CORPORATION (JP) 2023-10-03 US disclosed
CN-116253625-A Fluorine-containing allyl compound, modified bismaleimide resin, preparation method and application thereof 广东盈骅新材料科技有限公司 2023-06-13 CN disclosed
US-8143362-B2 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-03-27 US disclosed
WO-2011005515-A2 BIS-TRIFLUOROMETHYL HONOKIOL ANALOGS AND THEIR USE IN TREATING CANCERS ARBISER JACK I (US) 2011-01-13 WO disclosed
US-20100331444-A1 COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF 3M ESPE AG (A WHOLLY-OWNED SUBSIDUARY OF 3M COMPANY) 2010-12-30 US disclosed
US-7807730-B2 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M ESPE AG (DE) 2010-10-05 US disclosed
US-20060111464-A1 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M DEUTSCHLAND GMBH (DE) 2006-05-25 US disclosed
EP-1652889-A1 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M Espe AG (DE) 2006-05-03 EP disclosed
EP-1650263-A1 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof 3M Espe AG (DE) 2006-04-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331444-A1 COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF SMCHD1, CAD, ESD CA12 2030/4885CA1 1100/4885CA9 2805/4885
US-11773207-B2 Thiol compound, method for synthesizing same, and uses for said thiol compound TST, TMT1A, CTH CA12 2561/4885CA1 1231/4885CA9 2520/4885
US-20060111464-A1 Composition containing unsaturated silicone compounds, dental materials containing them and use thereof CAD, SMCHD1, SUPT16H CA12 2232/4885CA1 1048/4885CA9 2310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.